| Primary |
| Product Used For Unknown Indication |
20.6% |
| Drug Use For Unknown Indication |
20.1% |
| Otitis Media Acute |
8.9% |
| Urinary Tract Infection |
7.9% |
| Sinusitis |
7.5% |
| Ear Infection |
6.5% |
| Lyme Disease |
5.1% |
| Upper Respiratory Tract Infection |
4.2% |
| Pneumonia |
2.8% |
| Bronchitis |
2.3% |
| Prophylaxis |
2.3% |
| Skin Infection |
2.3% |
| Malaise |
1.9% |
| Pharyngitis |
1.9% |
| Depression |
1.4% |
| Escherichia Infection |
0.9% |
| Lung Infection |
0.9% |
| Lung Infiltration |
0.9% |
| Rheumatoid Arthritis |
0.9% |
| Arthritis |
0.5% |
|
| Vomiting |
22.0% |
| Rash |
9.8% |
| Pharmaceutical Product Complaint |
9.1% |
| Drug Ineffective |
6.8% |
| Urticaria |
6.8% |
| Product Quality Issue |
6.1% |
| Pruritus |
4.5% |
| Medication Error |
3.8% |
| Retching |
3.8% |
| Diarrhoea |
3.0% |
| Drug Hypersensitivity |
3.0% |
| Nausea |
3.0% |
| Therapeutic Response Unexpected |
3.0% |
| Drug Dispensing Error |
2.3% |
| Hypersensitivity |
2.3% |
| Overdose |
2.3% |
| Tremor |
2.3% |
| Viral Infection |
2.3% |
| Wrong Technique In Drug Usage Process |
2.3% |
| Abdominal Discomfort |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
50.0% |
| Prostatitis |
6.4% |
| Foetal Exposure During Pregnancy |
5.9% |
| Urinary Tract Infection |
4.3% |
| Pneumonia |
3.7% |
| Sinusitis |
3.2% |
| Blood Pressure |
2.7% |
| Depression |
2.7% |
| Multiple Myeloma |
2.7% |
| Upper Respiratory Tract Infection |
2.7% |
| Drug Use For Unknown Indication |
2.1% |
| Ear Infection |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Atrial Fibrillation |
1.6% |
| Crohn's Disease |
1.6% |
| Lyme Disease |
1.6% |
| Tonsillitis |
1.6% |
| Atypical Pneumonia |
1.1% |
| Dyspnoea |
1.1% |
| Gastric Disorder |
1.1% |
|
| Drug Hypersensitivity |
44.0% |
| Hypersensitivity |
7.1% |
| Diarrhoea |
4.8% |
| Rash |
4.8% |
| Vision Blurred |
4.8% |
| Urticaria |
3.6% |
| Vomiting |
3.6% |
| Anaphylactic Reaction |
2.4% |
| Drug Ineffective |
2.4% |
| Fatigue |
2.4% |
| No Adverse Event |
2.4% |
| Sepsis |
2.4% |
| Therapeutic Response Unexpected |
2.4% |
| Tooth Decalcification |
2.4% |
| Tooth Extraction |
2.4% |
| Urinary Tract Infection |
2.4% |
| Vomiting Projectile |
2.4% |
| Allergy To Plants |
1.2% |
| Erectile Dysfunction |
1.2% |
| Exposure During Pregnancy |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.2% |
| Drug Use For Unknown Indication |
14.1% |
| Pain |
5.6% |
| Depression |
4.7% |
| Hypertension |
4.5% |
| Bronchitis |
3.8% |
| Osteoporosis |
3.6% |
| Anxiety |
3.3% |
| Systemic Lupus Erythematosus |
3.3% |
| Asthma |
3.1% |
| Prophylaxis |
2.9% |
| Vitamin Supplementation |
2.7% |
| Contraception |
2.6% |
| Sinusitis |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Multiple Myeloma |
2.3% |
| Acne |
2.1% |
| Arthritis |
2.0% |
| Back Pain |
1.7% |
| Arthralgia |
1.7% |
|
| Weight Decreased |
19.8% |
| Vomiting |
8.9% |
| Wound Infection Staphylococcal |
8.5% |
| Pulmonary Embolism |
8.1% |
| White Blood Cell Count Increased |
5.0% |
| Sinusitis |
4.3% |
| Upper Respiratory Tract Infection |
4.3% |
| Wheezing |
4.3% |
| Vision Blurred |
3.9% |
| Weight Increased |
3.9% |
| Pain |
3.5% |
| Suicide Attempt |
3.5% |
| Tachypnoea |
3.1% |
| Vein Disorder |
3.1% |
| Anxiety |
2.7% |
| Cerebrovascular Accident |
2.7% |
| Maternal Exposure During Pregnancy |
2.7% |
| Urinary Tract Infection |
2.7% |
| Wound |
2.7% |
| Acute Hepatic Failure |
2.3% |
|
| Interacting |
| Coronary Artery Disease |
33.3% |
| Diabetes Mellitus |
33.3% |
| Sinusitis |
33.3% |
|
| No Adverse Event |
40.0% |
| Tendonitis |
40.0% |
| Tenderness |
20.0% |
|
